Johnson & Johnson vs Synchrony Financial — how do they compare? Johnson & Johnson trades at $250.66 (market cap $598.96B), while Synchrony Financial trades at $71.7 (market cap $24.69B). The key difference: Johnson & Johnson is far larger — about 24.3× Synchrony Financial's market cap, and Johnson & Johnson pays the higher dividend (2.15%). Which is the better fit depends on your goals.
| JNJ | SYF | |
|---|---|---|
Market Cap | $598.96B | $24.69B |
Volume | 6,156,228 | — |
Sector | Health | Financials |
52-Week High | $267.24 | $88.47 |
52-Week Low | $164.36 | $63.78 |
Enterprise Value | $631.90B | — |
Dividend Yield | 2.15% | 1.63% |
Trailing returns across standard periods
Latest headlines on both assets
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →Synchrony Financial is a premier consumer financial services company and the largest provider of private-label credit cards in the United States. Spun off from GE Capital in 2014, it operates through a unique B2B2C model, embedding its financing products within the ecosystems of major partners like Amazon, Lowe’s, and PayPal. Synchrony leverages deep data analytics and a diverse multi-platform strategy—spanning retail, health, and auto—to drive customer loyalty and provide specialized credit solutions at the point of sale.
Read more on SYF →